Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Glucose Monitoring: An Evaluation of Impact on Improving the Efficiency of Diagnostic Processes and Enhancing Patient Safety in the Management of Reactive and Spontaneous Hypoglycaemia

NCT04452396 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT04452396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Glucose Monitoring: An Evaluation of Impact on Improving the Efficiency of Diagnostic Processes and Enhancing Patient Safety in the Management of Reactive and Spontaneous Hypoglycaemia
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Terminated
Start date
December 1, 2019
Completion date
January 31, 2023
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycaemia night, hypoglycemia non-diabetic, hypoglycemia unawareness, hypoglycemia, reactive, insulin hypoglycemia, insulin resistance, insulinoma, insulinoma; malignant, pancreas, neuro endocrine tumours, spontaneous hypoglycemia